tradmap

IRON Earnings Disc Medicine, Inc.

Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Updated

Annual results

Diluted EPS (annual)
-$45 -$23 $0 2021 2022 2023 2024 2025
EPS
Net income (annual)
-$212M -$106M $0 2020 2021 2022 2023 2024 2025
Net income
Return on equity (annual)
-29% 57% 142% 0% 2020 2021 2022 2023 2024 2025
ROE

Quarterly results

Diluted EPS (quarterly)
-$38 -$19 $0 Q3 '22 Q2 '23 Q1 '24 Q3 '24 Q2 '25 Q1 '26
EPS
Net income (quarterly)
-$64M -$32M $0 Q3 '23 Q1 '24 Q3 '24 Q1 '25 Q3 '25 Q1 '26
Net income
Return on equity (quarterly)
-11% -5% 0% Q3 '23 Q1 '24 Q3 '24 Q1 '25 Q3 '25 Q1 '26
ROE

Reported EPS history

1–21 of 21
Q2 20262026-06-30-3.192026-07-3010-Q
Q1 20262026-03-31-1.652026-05-0510-Q
FY 20252025-12-31-6.012026-02-2610-K
Q3 20252025-09-30-4.392025-11-0610-Q
Q2 20262025-06-30-2.612026-07-3010-Q
Q1 20262025-03-31-1.022026-05-0510-Q
FY 20252024-12-31-3.962026-02-2610-K
Q3 20252024-09-30-2.982025-11-0610-Q
Q2 20252024-06-30-2.112025-08-0710-Q
Q1 20252024-03-31-1.092025-05-0710-Q
FY 20252023-12-31-3.422026-02-2610-K
Q3 20242023-09-30-2.452024-11-1210-Q
Q2 20242023-06-30-1.912024-08-0810-Q
Q1 20242023-03-31-1.202024-05-0910-Q
FY 20232022-12-31-45.052024-03-2110-K
Q3 20232022-09-30-37.732023-11-0910-Q
Q2 20232022-06-30-20.802023-08-1110-Q
Q1 20232022-03-31-10.672023-05-1510-Q
FY 20222021-12-31-40.952023-03-3110-K
Q3 20222021-09-30-1.372022-11-1010-Q
Q2 20222021-06-30-0.942022-08-1110-Q

Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Informational only — not financial advice.